BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20191867)

  • 1. [Obesity paradox].
    Aursulesei V; Cozma A; Datcu MD
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1006-15. PubMed ID: 20191867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and the "obesity paradox" in cardiovascular diseases.
    Lavie CJ; Milani RV; Ventura HO
    Clin Pharmacol Ther; 2011 Jul; 90(1):23-5. PubMed ID: 21691270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The obesity paradox, weight loss, and coronary disease.
    Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
    Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction.
    Douketis JD; Sharma AM
    Semin Vasc Med; 2005 Feb; 5(1):25-33. PubMed ID: 15968577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
    Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
    J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.
    Akbartabartoori M; Lean ME; Hankey CR
    Eur J Clin Nutr; 2008 Jan; 62(1):1-9. PubMed ID: 17342166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Body mass index and cardiovascular events: the "obesity paradox"].
    Andreotti F; Rio T; Lavorgna A; Coluzzi G; Santucci E; Cecchetti S; Pennestrì F; Crea F
    Recenti Prog Med; 2009 Oct; 100(10):447-50. PubMed ID: 20030166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease.
    Poulain M; Doucet M; Drapeau V; Fournier G; Tremblay A; Poirier P; Maltais F
    Chron Respir Dis; 2008; 5(1):35-41. PubMed ID: 18303100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does body mass index really matter in the management of heart failure?: a review of the literature.
    Sagar UN; Ahmed MM; Adams S; Whellan DJ
    Cardiol Rev; 2008; 16(3):124-8. PubMed ID: 18414183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obesity and cardiac failure].
    Galinier M; Pathak A; Roncalli J; Massabuau P
    Arch Mal Coeur Vaiss; 2005 Jan; 98(1):39-45. PubMed ID: 15724418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, weight loss, and cardiovascular health: is oxidative capacity a missing link?
    Phillips SA
    Am J Hypertens; 2008 Dec; 21(12):1277. PubMed ID: 19020508
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity paradox in patients with hypertension and coronary artery disease.
    Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
    Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
    Lavie CJ; Milani RV; Ventura HO
    J Am Coll Cardiol; 2009 May; 53(21):1925-32. PubMed ID: 19460605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and cardiovascular risk: the new public health problem of worldwide proportions.
    Scaglione R; Argano C; Di Chiara T; Licata G
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):203-12. PubMed ID: 15151469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
    Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
    Am J Med; 2010 Jul; 123(7):646-51. PubMed ID: 20609687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.